Table 1.
Structures | D50 [Gy] | Gamma(γ50) or m & n | References |
---|---|---|---|
Organs-at-risk (OAR) | |||
Bladder | 80.0 | m = 0.11 & n = 0.5 | Kutcher and Burman [29] |
Unspecific Pelvic Normal tissue | 55.0 | m = 0.13 & n = 0.15 | Kutcher and Burman [29] |
Rectum (1) | 81.9 | m = 0.19 & n = 0.23 | Rancati et al [30] |
Rectum (2)* | 75.7 | m = 0.14 & n = 0.24 | Rancati et al [30] |
Rectum (3)* | 55.9 | m = 0.16 & n = 1.03 | Tucker et al [31] |
Tumor Subvolume classification | |||
Intermediate risk (M) | 72.8 | γ50 = 2 | Levegrün et al [25] |
Very high risk (H+) | 82.3 | γ50 = 2 | |
Selected D50 and γ50 Combination | |||
H+-M22 | Nodule : Very high risk (H+), γ50 = 2 rPTV :Intermediate risk (M), γ50 = 2 |
Abbreviations: D50 = the dose yielding a 50% dose-response for a specific end point to either normal tissue complications or tumor control, γ50 = the normalized dose-response gradient, m = the parameter is related to the slope of the dose-response curve , n = the volume effect (cf. no volume effect has been assumed for individual normal tissue voxels when optimizing risk-adaptive optimization [5]),
= They were added to minimize NTCP model parameter dependency when calculating NTCP values (no use in an optimization process for risk-adaptive optimization).